Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/04/2003WO2003099314A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003WO2003099313A1 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099299A1 Agents and methods for the treatment of disorders associated with motor neuron degeneration
12/04/2003WO2003099298A1 Rna interference mediating small rna molecules
12/04/2003WO2003099275A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099264A1 Compositions and method for transmucosal drug delivery and cryoprotection
12/04/2003WO2003099262A1 Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
12/04/2003WO2003099236A1 Allograft bone composition having a gelatin binder
12/04/2003WO2003099227A2 Modulation of ptp1b signal transduction by rna interference
12/04/2003WO2003099207A2 Oral lactoferrin in the treatment of respiratory disorders
12/04/2003WO2003099204A2 Antisense modulation of inhibitor-kappa b kinase-beta expression
12/04/2003WO2003099202A2 Beta-secretase inhibitors
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099194A2 Pharmaceutical combination of pde5 inhibitors with ace inhibitors
12/04/2003WO2003098991A2 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003WO2003088920A3 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
12/04/2003WO2003082196A3 Combination therapy using trefoil peptides
12/04/2003WO2003075977A3 Agglomerated particles for aerosol drug delivery
12/04/2003WO2003072771A3 Method of preparing a treatment product using a togaviridae expression construct
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003066673A8 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/04/2003WO2003064460A8 Two gonadotropin releasing hormones and a method to isolate the same
12/04/2003WO2003063785A3 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
12/04/2003WO2003062386A3 Syndecans and angiogenesis
12/04/2003WO2003060468A3 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
12/04/2003WO2003060096A3 Assay for the detection of factors that modulate the expression of ingap
12/04/2003WO2003059290A3 Diagnostic and therapeutic uses of topors
12/04/2003WO2003057898A8 Methods and materials for modulating p2x2
12/04/2003WO2003057820A3 Peptide activators of vegf
12/04/2003WO2003057179A3 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
12/04/2003WO2003057170A3 Oral insulin therapy
12/04/2003WO2003057168A3 Cancer-associated epitope
12/04/2003WO2003055439A3 Her2/neu target antigen and use of same to stimulate an immune response
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003053351A3 A NOVEL REGULATORY ELEMENT WITHIN THE IL-Iα PROMOTER AND USES THEREOF
12/04/2003WO2003050540A3 Flexible method and apparatus for high throughput production and purification of multiple proteins
12/04/2003WO2003050281A3 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
12/04/2003WO2003050136A3 Peptide t stimulates ctl responses
12/04/2003WO2003048362A3 Suppression of polymeric alleles
12/04/2003WO2003048328A3 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
12/04/2003WO2003048188A3 15603, a human ion channel family member
12/04/2003WO2003045987A3 A food grade lantibiotic from streptococcus macedonicus and uses thereof
12/04/2003WO2003045980A3 Glycopeptide remodeling using amidases
12/04/2003WO2003035010A3 Thymosin augmentation of genetic immunization
12/04/2003WO2003034990A3 Angiopoietins and methods of use thereof
12/04/2003WO2003032920A3 Oligonucleotide modulation of cell adhesion
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003030617A3 Antisense modulation of creb expression
12/04/2003WO2003029417A3 Nutrient medium for maintaining neural cells in injured nervous system
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003028001A3 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol
12/04/2003WO2003025579A3 Use of heart fatty acid binding protein
12/04/2003WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure
12/04/2003WO2003022203A3 Products and methods for treating microbial infections
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003020901A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003018755A3 Wild-type ras as a cancer therapeutic agent
12/04/2003WO2003016560A3 Methods for diagnosing and treating neoplasias using nf-at transcription factors
12/04/2003WO2003015748A3 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
12/04/2003WO2003014152A3 Phosphatidylinositol 5-phosphate-binding proteins
12/04/2003WO2003014145A3 Peptides that bind to atherosclerotic lesions
12/04/2003WO2003012059A3 Antisense modulation of cyclin d2 expression
12/04/2003WO2003012043A3 Enhancing organ maturity in neonates and predicting their duration of intensive care
12/04/2003WO2003009704A3 Enteral compositions for the prevention and/or treatment of sepsis
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003004531A3 Regulation of human somatostatin receptor-like protein
12/04/2003WO2003003971A3 Use of antidiabetics for making a medicine with cicatrizing effect
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002098515A3 Topical treatments using alkanolamines
12/04/2003WO2002098442A3 Composition containing phytase
12/04/2003WO2002096936A3 Daptomycin and related analogs in crystalline form, their preparation and use
12/04/2003WO2002087507A3 Breast cancer-associated genes and uses thereof
12/04/2003WO2002086134A3 Buffer solution for electroporation and a method comprising the use of the same
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002081510A3 Proteins, polynucleotides encoding them and methods of using the same
12/04/2003WO2002079383A3 Fizz1 for metabolism regulation
12/04/2003WO2002074193A3 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002070555A3 Method of modulating the proliferation of medullary thyroid carcinoma cells
12/04/2003WO2002068635A3 Methods of inhibiting expression of a target gene in mammalian cells
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002064777A3 Proteins 7b6 and 11b4 and dna sequences encoding the same
12/04/2003WO2002064742A3 Compounds effecting neuron remodeling and assays for same
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002043774A3 Compositions and therapeutical use of polynucleotides encoding tcrs
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003US20030226169 DNA sequences encoding antifungal proteins
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030225300 Compounds and compositions for delivering active agents
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225254 Comprises monoclonal antibody for treating and prevention of tumor progression; antitumor agents
1 ... 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 ... 3163